| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Hypermelanosis
[description not available] | 0 | 3.89 | 2 | 1 |
B16 Melanoma
[description not available] | 0 | 2.5 | 2 | 0 |
Cancer of Skin
[description not available] | 0 | 2.08 | 1 | 0 |
Skin Neoplasms
Tumors or cancer of the SKIN. | 0 | 2.08 | 1 | 0 |
Hyperpigmentation
Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance. | 0 | 3.89 | 2 | 1 |
Innate Inflammatory Response
[description not available] | 0 | 2.1 | 1 | 0 |
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 2.1 | 1 | 0 |
Carcinogenesis
The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years. | 0 | 2.11 | 1 | 0 |
Necrosis
The death of cells in an organ or tissue due to disease, injury or failure of the blood supply. | 0 | 2.13 | 1 | 0 |
Facial Dermatoses
Skin diseases involving the FACE. | 0 | 3.51 | 1 | 1 |
Skin Aging
The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight. | 0 | 2.15 | 1 | 0 |